Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Fentanyl-induced Cough
NCT03126422Phase 1Unknown
- Sponsor
- Yangzhou University
- Start
- May 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in cough, sponsored by Yangzhou University. Primary endpoint: Incidence of cough at 10 months. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
cough
Beyond the preview
Go deeper on NCT03126422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126422.